Journal of Current Ophthalmology最新文献

Topical Insulin for Neurotrophic-Related Epithelial Defects: Where do We Stand? A Systematic Review. 外用胰岛素治疗神经营养相关上皮缺陷：我们的现状如何？系统综述。

IF 1.2

Journal of Current Ophthalmology Pub Date : 2024-10-16 eCollection Date: 2024-01-01 DOI: 10.4103/joco.joco_32_24

Colette Wouters, Isabelle Saelens, Heleen Delbeke

{"title":"Topical Insulin for Neurotrophic-Related Epithelial Defects: Where do We Stand? A Systematic Review.","authors":"Colette Wouters, Isabelle Saelens, Heleen Delbeke","doi":"10.4103/joco.joco_32_24","DOIUrl":"10.4103/joco.joco_32_24","url":null,"abstract":"Purpose: To review the existing literature to evaluate the utility of insulin eye drops as a treatment for neurotrophic-related epithelial defects.Methods: A comprehensive literature search of Medline, Embase, and Web of Science and additional manual searches were conducted using relevant keywords. All articles published from January 2005 to January 2024 were examined. Studies on the use of topical insulin drops in neurotrophic epithelial defects were included.Results: A total of 16 articles were found relevant to be discussed in the review. All included patients had neurotrophic-related epithelial defects ranging from 3.8 mm2 to 144 mm2. After treatment with topical insulin, most of the epithelial defects showed a complete epithelialization. Various concentrations and types of insulin were used. The studies also varied in the type of vehicle used in the preparation of insulin drops. Two randomized controlled trials demonstrated that topical insulin drops were more effective than conventional treatment with artificial tears or autologous serum. All included studies, except for two, reported the absence of local or systemic side effects.Conclusions: Topical insulin is a promising and effective (adjuvant) treatment for neurotrophic keratopathy. It facilitates the healing of neurotrophic epithelial defects and offers many advantages over the current treatment options; insulin is widely available and it is relatively inexpensive. Topical insulin drops do not affect systemic blood glucose levels and are well tolerated. However, further investigation is needed.","PeriodicalId":15423,"journal":{"name":"Journal of Current Ophthalmology","volume":"36 1","pages":"9-22"},"PeriodicalIF":1.2,"publicationDate":"2024-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11567610/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142648051","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Ocular Surface Assessment in Patients with Obstructive Sleep Apnea Syndrome. 阻塞性睡眠呼吸暂停综合征患者的眼表评估。

IF 1.2

Journal of Current Ophthalmology Pub Date : 2024-10-16 eCollection Date: 2024-01-01 DOI: 10.4103/joco.joco_173_23

Reza Ghaffari, Hamed Ghassemi, Khosro Sadeghniiat Haghighi, Mehran Zarei-Ghanavati, Golshan Latifi, Karzan Nebi Kheder, Ahmad Masoumi, Pedram Afshar

{"title":"Ocular Surface Assessment in Patients with Obstructive Sleep Apnea Syndrome.","authors":"Reza Ghaffari, Hamed Ghassemi, Khosro Sadeghniiat Haghighi, Mehran Zarei-Ghanavati, Golshan Latifi, Karzan Nebi Kheder, Ahmad Masoumi, Pedram Afshar","doi":"10.4103/joco.joco_173_23","DOIUrl":"10.4103/joco.joco_173_23","url":null,"abstract":"Purpose: To evaluate the prevalence of dry eye, meibomian gland dysfunction (MGD), and conjunctivochalasis in patients with obstructive sleep apnea (OSA).Methods: We included 37 patients diagnosed with OSA according to polysomnography. The control group comprised 31 subjects. The study participants underwent a complete ophthalmic examination and ocular surface assessment. Meibography was done using infrared imaging. Furthermore, tear meniscus height was measured using anterior segment optical coherence tomography.Results: The mean age of the OSA and control groups were 50.3 ± 9.0 and 50.3 ± 8.0, respectively (P = 0.77). The mean scale for meibomian gland expression, meibomian gland plugging, and lid margin telangiectasia was similar in both groups. The meiboscores of the upper and lower eyelids were similar in both groups (upper meiboscores of 0.67 ± 0.48 and 0.37 ± 0.49 in OSA and control group, P = 0.180 and lower meiboscores of were 0.47 ± 0.57 and 0.22 ± 0.42 in OSA and control group, P = 0.179). The mean tear break-up time (TBUT) was significantly lower in the OSA group (8.17 ± 3.70 compared to 11.47 ± 4.52, P < 0.001). Upper and lower tear meniscus height were 186.14 ± 40.11 μm and 199.59 ± 37.22 μm and 237.25 ± 82.86 μm and 218.59 ± 68.8 μm in OSA and control group, respectively (P = 0.221, P = 0.166). The mean conjunctivochalasis grading score was 0.92 ± 0.72 and 0.81 ± 0.65 in the OSA and control groups, respectively (P = 0.143).Conclusions: Despite decreased TBUT in patients with OSA, other dry eye parameters are not altered in these patients. Moreover, the frequency of MGD and conjunctivochalasis is not higher in OSA patients.","PeriodicalId":15423,"journal":{"name":"Journal of Current Ophthalmology","volume":"36 1","pages":"42-45"},"PeriodicalIF":1.2,"publicationDate":"2024-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11567611/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142648036","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

How Safe is Nd: YAG Laser Capsulotomy in Patients with Uveitis? Outcomes of a Long-Term Study. 掺钕钇钕石榴石（Nd: YAG）激光囊肿切开术对葡萄膜炎患者的安全性如何？一项长期研究的结果。

IF 1.2

Journal of Current Ophthalmology Pub Date : 2024-10-16 eCollection Date: 2024-01-01 DOI: 10.4103/joco.joco_221_23

Mukesh Rajpoot, Harshraj Nehra, Vinod Sharma, Rahul Bhargava, Kanakambari Pandey, Bhavya Mehta, Gautam Kalra, P L Sireesha Reddy

{"title":"How Safe is Nd: YAG Laser Capsulotomy in Patients with Uveitis? Outcomes of a Long-Term Study.","authors":"Mukesh Rajpoot, Harshraj Nehra, Vinod Sharma, Rahul Bhargava, Kanakambari Pandey, Bhavya Mehta, Gautam Kalra, P L Sireesha Reddy","doi":"10.4103/joco.joco_221_23","DOIUrl":"10.4103/joco.joco_221_23","url":null,"abstract":"Purpose: To study the outcomes and complications of Nd: YAG laser capsulotomy in patients with uveitis.Methods: This study retrospectively evaluated outcomes of Nd: YAG laser capsulotomy in 260 eyes of 260 patients with uveitis. The main indications for performing capsulotomy were a visually significant posterior capsule opacification (PCO) and inability to visualize the posterior segment. The presence of 5 or <5 cells per high-power field in the anterior chamber for a minimum period of 3 months was a prerequisite for capsulotomy.Results: The mean age of patients was 52.8 ± 11.3 (range, 38-75 years). The incidence of PCO in the study was 22.4%. The mean follow-up was 21.5 ± 11.3 months postcapsulotomy. The mean best-corrected visual acuity (BCVA) improved in 161 (62%) eyes after capsulotomy. The BCVA remained stable in 50 (19.3%) eyes due to preexisting ocular pathology involving the macular area. There was worsening of BCVA in 49 (18.8%) eyes. The main causes of worsening of BCVA were sustained intraocular pressure (IOP) elevation (n = 13%), cystoid macular edema (CME) (n = 8.5%), and retinal detachment (RD) (n = 2.7%), respectively. Ninety-one percent (n = 20) of patients with CME had exaggerated postlaser inflammation and recurrent uveitis. The presence of posterior vitreous detachment (PVD) and higher laser energy levels were significant risk factors for RD.Conclusions: Nd: YAG laser capsulotomy in patients with uveitis may be associated with complications. Inflammation and IOP should be well controlled before initiating laser capsulotomy. Capsulotomy should be performed with caution in patients with preexisting PVD.","PeriodicalId":15423,"journal":{"name":"Journal of Current Ophthalmology","volume":"36 1","pages":"72-77"},"PeriodicalIF":1.2,"publicationDate":"2024-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11567599/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142647907","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Cabozantinib-Associated Exudative Retinal Detachment and Choroiditis: A Case Report. 卡博替尼相关性渗出性视网膜脱离和脉络膜炎：病例报告。

IF 1.2

Journal of Current Ophthalmology Pub Date : 2024-10-16 eCollection Date: 2024-01-01 DOI: 10.4103/joco.joco_242_23

Kirk A J Stephenson, Bryon R McKay, Katherine E Paton

{"title":"Cabozantinib-Associated Exudative Retinal Detachment and Choroiditis: A Case Report.","authors":"Kirk A J Stephenson, Bryon R McKay, Katherine E Paton","doi":"10.4103/joco.joco_242_23","DOIUrl":"10.4103/joco.joco_242_23","url":null,"abstract":"Purpose: To describe the first reported instance of an acute chorioretinal inflammatory response to cabozantinib.Methods: Case report.Results: A 54-year-old Asian male presented with blurred vision 2 weeks following the commencement of cabozantinib for metastatic renal cell carcinoma. Ophthalmic examination revealed bilateral exudative retinal detachments and choroiditis in a pattern similar to Vogt-Koyanagi-Harada disease. Further investigations revealed latent tuberculosis (TB), and management of this ocular adverse event was with cabozantinib cessation, high-dose oral prednisone, single-agent anti-TB therapy, and methotrexate. Return of visual function and ocular anatomy occurred within 1 month.Conclusions: Modern pharmacotherapy for metastatic cancer may increase survival, but a range of ocular and systemic adverse events are frequently seen. Screening and early intervention can mitigate adverse events and treatment burden, while maximizing benefits for this disadvantaged patient group.","PeriodicalId":15423,"journal":{"name":"Journal of Current Ophthalmology","volume":"36 1","pages":"103-106"},"PeriodicalIF":1.2,"publicationDate":"2024-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11567612/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142647942","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Deep Learning Algorithm for Keratoconus Detection from Tomographic Maps and Corneal Biomechanics: A Diagnostic Study. 从断层扫描图和角膜生物力学检测角膜炎的深度学习算法：诊断研究。

IF 1.2

Journal of Current Ophthalmology Pub Date : 2024-10-16 eCollection Date: 2024-01-01 DOI: 10.4103/joco.joco_18_24

Wiyada Quanchareonsap, Ngamjit Kasetsuwan, Usanee Reinprayoon, Yonrawee Piyacomn, Thitima Wungcharoen, Monthira Jermjutitham

{"title":"Deep Learning Algorithm for Keratoconus Detection from Tomographic Maps and Corneal Biomechanics: A Diagnostic Study.","authors":"Wiyada Quanchareonsap, Ngamjit Kasetsuwan, Usanee Reinprayoon, Yonrawee Piyacomn, Thitima Wungcharoen, Monthira Jermjutitham","doi":"10.4103/joco.joco_18_24","DOIUrl":"10.4103/joco.joco_18_24","url":null,"abstract":"Purpose: To develop an artificial intelligence (AI) approach for differentiating between normal cornea, subclinical, and keratoconus (KC) using tomographic maps from Pentacam (Oculus) and corneal biomechanics from Corvis ST (Oculus).Methods: A total of 1,668 tomographic (769 patients) and 611 biomechanical (307 patients) images from the Chula Refractive Surgery Center, King Chulalongkorn Memorial Hospital were included. The sample size was divided into the Pentacam and combined Pentacam-Corvis groups. Different convolutional neural network approaches were used to enhance the KC and subclinical KC detection performance.Results: AI model 1, which obtained refractive maps from Pentacam, achieved an area under the receiver operating characteristic curve (AUC) of 0.938 and accuracy of 0.947 (sensitivity, 90.8% and specificity, 96.9%). AI model 2, which added dynamic corneal response and the Vinciguerra screening report from Corvis ST to AI Model 1, achieved an AUC of 0.985 and accuracy of 0.956 (sensitivity, 93.0% and specificity, 94.3%). AI model 3, which added the corneal biomechanical index to AI Model 2, reached an AUC of 0.991 and accuracy of 0.956 (sensitivity, 93.0% and specificity, 94.3%).Conclusions: Our study showed that AI models using either anterior corneal curvature alone or combined with corneal biomechanics could help classify normal and keratoconic corneas, which would make diagnosis more accurate and would be helpful in decision-making for the treatment.","PeriodicalId":15423,"journal":{"name":"Journal of Current Ophthalmology","volume":"36 1","pages":"46-53"},"PeriodicalIF":1.2,"publicationDate":"2024-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11567606/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142647954","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Optical Coherence Tomography Angiography Vessel Density in Healthy, Glaucoma Suspect, and Glaucoma Eyes. 健康眼、疑似青光眼眼和青光眼眼的光学相干断层血管造影血管密度。

IF 1.2

Journal of Current Ophthalmology Pub Date : 2024-10-16 eCollection Date: 2024-01-01 DOI: 10.4103/joco.joco_270_23

Umesh Belbase, Indra Man Maharjan, Anup Subedi

{"title":"Optical Coherence Tomography Angiography Vessel Density in Healthy, Glaucoma Suspect, and Glaucoma Eyes.","authors":"Umesh Belbase, Indra Man Maharjan, Anup Subedi","doi":"10.4103/joco.joco_270_23","DOIUrl":"10.4103/joco.joco_270_23","url":null,"abstract":"Purpose: To evaluate and compare optical coherence tomography angiography (OCTA) retinal vasculature measurements in healthy, glaucoma suspect (GS), and glaucoma patients.Methods: One hundred fourteen eyes with good quality OCTA pictures were included from 38 healthy, 38 GS, 38 and primary open-angle glaucoma (POAG) participants. The information on retinal vasculature was summarized as a vessel density map and as vessel density (%), which is the fraction of the flowing vessel area over the total area examined. The superior, inferior, nasal, and temporal quadrants, as well as whole vessel density (wVD) and peripapillary vessel density (ppVD) data taken from the retinal nerve fiber layer, were studied. Global indices of the visual field were correlated with vessel density measurement.Results: Mean vessel density was significantly lower in POAG eyes compared with GSs and healthy eyes (wVD) 45.34% ± 6.64%, 50.06% ± 1.97% and 53.06% ± 2.12%, respectively (P < 0.001), and ppVD 47.42% ± 7.73%, 47.42% ± 7.73% and 56.074% ± 2.71%, respectively (P < 0.001). A linear relationship between vessel density (wVD and ppVD) and global indices of the visual field (mean deviation [MD] and pattern standard deviation [PSD]) shows a significant (P < 0.001) relation. R 2 is 0.35, 0.36, 0.36, and 0.33 for MD and wVD, PSD and wVD, PSD and ppVD, and MD and ppVD, respectively.Conclusions: For distinguishing between healthy and glaucoma eyes, OCTA vessel density demonstrated near similar diagnostic accuracy to visual field tests. These findings imply that OCTA measurements reflect damage to tissues important in the pathogenesis of POAG.","PeriodicalId":15423,"journal":{"name":"Journal of Current Ophthalmology","volume":"36 1","pages":"31-36"},"PeriodicalIF":1.2,"publicationDate":"2024-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11567607/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142648045","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Effect of Eplerenone Treatment in Patients with Central Serous Retinopathy: A Double-Blind Randomized Clinical Trial. 依普利酮对中心性浆液性视网膜病变患者的治疗效果：双盲随机临床试验。

IF 1.2

Journal of Current Ophthalmology Pub Date : 2024-10-16 eCollection Date: 2024-01-01 DOI: 10.4103/joco.joco_13_22

Mohammadreza Akhlaghi, Alireza Dehghani, Farzan Kianersi, Mohammad Reza Khalili, Mohammad Tohidi, Hamidreza Jahanbani-Ardakani

{"title":"Effect of Eplerenone Treatment in Patients with Central Serous Retinopathy: A Double-Blind Randomized Clinical Trial.","authors":"Mohammadreza Akhlaghi, Alireza Dehghani, Farzan Kianersi, Mohammad Reza Khalili, Mohammad Tohidi, Hamidreza Jahanbani-Ardakani","doi":"10.4103/joco.joco_13_22","DOIUrl":"10.4103/joco.joco_13_22","url":null,"abstract":"Purpose: To evaluate the efficacy of eplerenone in central serous chorioretinopathy (CSCR) patients in a clinical trial design.Methods: In this double-blind clinical trial, naive acute. CSCR patients were divided into two groups: treatment with eplerenone 25 mg daily in the 1st week followed by 50 mg for the next 3 weeks and placebo group. Best-corrected visual acuity (BCVA), central macular thickness (CMT), macular volume (MV), and choroidal thickness (CT) were measured before and after 1 month of the intervention using the optical coherence tomography technique.Results: Thirty-one CSCR (male: 23, female: 8) and 25 CSCR patients (male: 18, female: 7) with the mean age of 35.65 ± 5.94 and 37.08 ± 6.41 years were recruited and divided randomly into treatment and placebo groups, respectively. BCVA improved significantly in the treatment group (from 0.28 ± 0.26 to 0.11 ± 0.14, P = 0.002) compared with the placebo group (from 0.31 ± 0.26 to 0.21 ± 0.14, P = 0.052). Although CT, CMT, and MV improved significantly in each group, there were no significant differences between the groups.Conclusion: In this study, we found favorable short-term clinical effects of eplerenone in acute CSCR patients, showing the pivotal role of mineralocorticoid receptors in the retina.","PeriodicalId":15423,"journal":{"name":"Journal of Current Ophthalmology","volume":"36 1","pages":"61-65"},"PeriodicalIF":1.2,"publicationDate":"2024-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11567597/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142647860","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Diffuse Unilateral Subacute Neuroretinitis: A Case Report Documenting Transretinal Migration of Nematodes. 弥漫性单侧亚急性神经视网膜炎：记录线虫经视网膜迁移的病例报告。

IF 1.2

Journal of Current Ophthalmology Pub Date : 2024-10-16 eCollection Date: 2024-01-01 DOI: 10.4103/joco.joco_345_22

Hassan Behboudi, Yousef Alizadeh, Maryam Dourandeesh, Ali Sanaye Abbasi, Ehsan Najibzadeh, Amin Nabavi

{"title":"Diffuse Unilateral Subacute Neuroretinitis: A Case Report Documenting Transretinal Migration of Nematodes.","authors":"Hassan Behboudi, Yousef Alizadeh, Maryam Dourandeesh, Ali Sanaye Abbasi, Ehsan Najibzadeh, Amin Nabavi","doi":"10.4103/joco.joco_345_22","DOIUrl":"10.4103/joco.joco_345_22","url":null,"abstract":"Purpose: To report two cases of diffuse unilateral subacute neuroretinitis (DUSN) from northern Iran and to present the sequential imaging.Methods: Two patients with large subretinal nematodes were evaluated and managed in our clinic. Serial fundus photography and optical coherence tomography (OCT) imaging were used to document the course of the disease. Laser photocoagulation was administered to manage the patients.Results: The migration of the nematodes from subinternal limiting membrane space to subretinal space was documented in one case, coinciding with the onset of inflammatory and destructive processes. Both patients were successfully managed using laser photocoagulation alone. Follow-up examinations revealed partial recovery of the outer retinal layers and improvement in visual acuity. Nevertheless, some persistent atrophy in the retinal nerve fiber layer and ellipsoid layer was noted in the final examination.Conclusions: We presented two cases of DUSN from northern Iran, with OCT documentation of transretinal migration in one case. Photocoagulation laser alone is an effective treatment modality in the early stage. The suboptimal final visual acuity appears to be linked to both inner and outer retinal layers' damage.","PeriodicalId":15423,"journal":{"name":"Journal of Current Ophthalmology","volume":"36 1","pages":"107-110"},"PeriodicalIF":1.2,"publicationDate":"2024-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11567602/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142650527","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Myopia Controlling using Low Dose Atropine Eye Drop. 使用小剂量阿托品滴眼液控制近视。

IF 1.2

Journal of Current Ophthalmology Pub Date : 2024-10-16 eCollection Date: 2024-01-01 DOI: 10.4103/joco.joco_344_22

Zhale Rajavi, Bahareh Kheiri, Kourosh Sheibani, Hamideh Sabbaghi

{"title":"Myopia Controlling using Low Dose Atropine Eye Drop.","authors":"Zhale Rajavi, Bahareh Kheiri, Kourosh Sheibani, Hamideh Sabbaghi","doi":"10.4103/joco.joco_344_22","DOIUrl":"10.4103/joco.joco_344_22","url":null,"abstract":"Purpose: To determine myopic progression, axial length elongation, best-corrected visual acuity (BCVA), pupil dilation, and accommodation amplitude following 24 months of Atropine 0.01% usage among progressive myopic patients.Methods: Fifty-one progressive myopic patients (age range, 3.5-17 years) were included in the present study. Fifteen patients were excluded due to loss to follow-up (eight patients) and Atropine complications (seven patients) and 36 patients continued therapy. Myopic progression, axial length, far and near BCVA, pupil diameter, and accommodation amplitude were measured at baseline examination and repeated every 6 months up to 2 years. All patients were recommended to instill one drop of Atropine 0.01% in each eye every night. Absolute success of therapy was defined as myopic progression ≤0.50 diopter (D) and axial length growth ≤0.2 mm per year.Results: Mean myopic progression was 0.16 and 1.28 D and mean axial length change was 0.05 and 0.69 mm at months 12 and 24, respectively. Pupil dilation was 1.26 and 1.84 mm and accommodation reduction was 3.38 and 3.37 D at the same follow-ups, while BCVA was not changed. Absolute success rate for myopic progression control was 56.8% at 12 months and 70.8% at 24 months follow-up. In addition, the success rate in respect to axial length changes was 44.4% and 58.3% at the same time points.Conclusions: Atropine 0.01% can slow myopic progression and axial length elongation at least in 50% of myopic cases at 12- and 24-month follow-up with no significant complications. Therefore, Atropine therapy is recommended in cases of progressive myopia in children and teenagers.","PeriodicalId":15423,"journal":{"name":"Journal of Current Ophthalmology","volume":"36 1","pages":"82-88"},"PeriodicalIF":1.2,"publicationDate":"2024-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11567600/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142648033","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Can Inactivated Coronavirus Disease 2019 Vaccine Cause Bilateral Neurotrophic Keratopathy? 2019 年冠状病毒病灭活疫苗会导致双侧神经营养性角膜病吗？

IF 1.2

Journal of Current Ophthalmology Pub Date : 2024-10-16 eCollection Date: 2024-01-01 DOI: 10.4103/joco.joco_224_23

Selman Belviranli, Refik Oltulu, Enver Mirza, Mehmet Adam, Ali Osman Gundogan

{"title":"Can Inactivated Coronavirus Disease 2019 Vaccine Cause Bilateral Neurotrophic Keratopathy?","authors":"Selman Belviranli, Refik Oltulu, Enver Mirza, Mehmet Adam, Ali Osman Gundogan","doi":"10.4103/joco.joco_224_23","DOIUrl":"10.4103/joco.joco_224_23","url":null,"abstract":"Purpose: To present a case of bilateral neurotrophic keratopathy (NK) following an inactivated coronavirus disease 2019 (COVID-19) vaccine administration.Methods: Case report.Results: A 46-year-old female patient was referred to our cornea department with unhealing corneal epithelial defects in both eyes. The patient's complaints, including ocular redness, sensitivity to light and blurred vision, started 1 week after the second dose of CoronaVac® vaccine and continued to increase for 2 months. Ophthalmological examination revealed mild ocular redness, epithelial defects in the central cornea, and decreased corneal sensitivity in both eyes. No pathology that could cause NK was detected in the patient's anamnesis and tests. Treatment including bandage contact lens application, autologous serum eye drops, preservative-free artificial tears, and oral doxycycline resulted in closure of the epithelial defect on the 10th day, and on the 2-month follow-up visit, it was observed that corneal sensitivity had increased.Conclusions: In the presented case, it is thought that bilateral NK may be associated with the vaccine due to the chronological relationship between the vaccine administration and the lack of any other explanatory etiology. A cure was achieved in a short time with appropriate treatment, and the increase in corneal sensitivity over time indicates that the corneal neuropathy was reversible. Nowadays, with the worldwide administration of COVID-19 vaccines, ophthalmologists should keep in mind that, although rare, NK manifestation may still be encountered after vaccination.","PeriodicalId":15423,"journal":{"name":"Journal of Current Ophthalmology","volume":"36 1","pages":"99-102"},"PeriodicalIF":1.2,"publicationDate":"2024-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11567604/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142647947","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0